Most Recent Articles by Lauren Grygotis
Researchers examined real-world characteristics of patients receiving albuterol multidose dry powder inhaler or short-acting β2 agonists with short-acting β2 agonists for asthma and chronic obstructive pulmonary disease.
Results from an online survey show that patients receiving Hizentra were satisfied with treatment.
Eleven medical societies are calling on Congress to preserve patient access to Part B therapies by preventing CMS from penalizing physicians who provide these treatments.
The AHA has released their concerns about the Republican tax reform bill.
Gastroesophageal reflux disease (GERD) is associated with long-term risk of pneumonia, especially in the younger population and in patients who have been treated with proton pump inhibitors.